Search

everythinglearnresearchcommunity

for

Search:↓

New techniques in hair restoration surgery can fix unnatural results from old methods, improving patient self-esteem.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

The document concludes that choosing the right forehead and brow lifting technique based on individual patient characteristics is crucial to prevent complications and achieve desired results.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Umbilical cord-derived media is safe and effective for hair growth.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Reconstruct lips with proper planning, templates, and revisions for appearance and function.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Targeted cancer therapies often cause serious skin problems that need careful management.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Using cheek skin and cartilage grafts for nose reconstruction after skin cancer surgery can maintain shape and function but may require multiple surgeries and hair removal in men.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

JAK inhibitors help with skin conditions but need more research on dosing and safety.